Cary Street Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Cary Street Partners's IDXX Position: Q2 2026 in Review
Cary Street Partners reduced its Idexx Laboratories (IDXX) stake by 2% in Q2 2026, selling an estimated $3.37K and leaving 301 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #962.
Cary Street Partners first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $203K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Cary Street Partners held 301 shares of Idexx Laboratories worth $158K as of Q2 2026.
- Cary Street Partners sold 6 Idexx Laboratories shares in Q2 2026, an estimated $3.37K.
- Idexx Laboratories made up ﹤0.01% of Cary Street Partners's portfolio in Q2 2026, its #962 holding.
- Cary Street Partners first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
- Cary Street Partners's Idexx Laboratories position peaked at $203K in Q4 2025.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.